NHI.no
Annonse
Informasjon

Testikkelkreft

Testikkelkreft er utvikling av ondartet svulst i en av testiklene. Tilstanden debuterer vanligvis med at du finner en kul i testikkelen, eller du har merket ubehag i en testikkel.

Testikkelkreft kan gi symptomer som lettere smerter, stikninger eller tyngdefornemmelser i den angrepne testikkelen.

Sist oppdatert:

22. juli 2020

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Testikkelkreft . Referanselisten for dette dokumentet vises nedenfor

  1. Baird DC, Meyers GJ, Hu JS. Testicular Cancer: Diagnosis and Treatment. Am Fam Physician. 2018;97(4):261-268. PubMed
  2. Sobin LH, Witterkind C: TNM classification of malignant tumours., UICC Wiley-Liss, 2007.
  3. International Germ Cell Consensus Classification: a prognostic factor- based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15: 594-603. PubMed
  4. Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av testikkelkreft. Sist faglig oppdatert: 15. april 2021. www.helsebiblioteket.no
  5. Kreftregisteret. Cancer in Norway 2019. Oslo: Kreftregisteret, 2020. www.kreftregisteret.no.
  6. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev. 2010 May. 19(5):1151-9.
  7. Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G et al. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol 2005; 16: 863-8. PubMed
  8. Lip SZ, Murchison LE, Cullis PS, Govan L, Carachi R. A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child. 2013;98(1):20–26. PMID: 23193201 PubMed
  9. Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. . BMJ 2000; 321: 789-92. PubMed
  10. Hemminki K, Chen B. Familial risks in testicular cancer as aetiological clues. Int J Androl 2006; 29:205. PubMed
  11. Levin HS. Tumors of the testis in intersex syndromes. Urol Clin North Am 2000; 27: 543-51. PubMed
  12. Shephard EA, Hamilton WT. Selection of men for investigation of possible testicular cancer in primary care: a large case-control study using electronic patient records. Br J Gen Pract 2018. pmid:29970393 PubMed
  13. Oldenburg J, Lehne G, Fosså S. Testikkelkreft. Tidsskr Nor Legeforen 2008; 128: 457-60. PubMed
  14. Albers P, Albrecht W, Algaba F, et al.; European Association of Urology. Guidelines on testicular cancer: 2015 update. Eur Urol. 2015;68(6):1054–1068. PMID: 26297604 PubMed
  15. Coursey Moreno C, Small WC, Camacho JC, et al. Testicular tumors: what radiologists need to know—differential diagnosis, staging, and management. Radiographics. 2015;35(2):400–415.
  16. Steele GS, Richie JP, Oh WK, Michaelson MD. Clinical manifestations, diagnosis, and staging of testicular germ cell tumors. UpToDate, last updated Jan 25, 2021. UpToDate
  17. Venkitaraman R, Johnson B, Huddart RA et al. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours. BJU Int 2007; 100: 30-2. PubMed
  18. Krege S, Beyer J, Souchon R, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EHCCCG): Part I. European Urology 2008; 53: 478-96. PubMed
  19. Krege S, Beyer J, Souchon R, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EHCCCG): Part II. European Urology 2008; 53: 497-513. PubMed
  20. Einhorn LH, Williams SD, Chamness A et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 2007; 357: 340-8. New England Journal of Medicine
  21. Brydoy M, Oldenburg J, Klepp O et al. Self-reported paresthesias, Raynaud’s phenomena, tinnitus, and hearing impairment in a large cohort of long-term testicular cancer (TC) survivors. J Clin Oncol (Meeting Abstracts) 2006; 24: 4547. PubMed
  22. Choo R, Thomas G, Woo T et al. Long-term outcome of postorchiectomy surveillance for stage I testicular seminoma. Int J Radiat Oncol Biol Phys 2005; 61: 736-40. PubMed
  23. Warde P, Chung P, Sturgeon J et al. Should surveillance be considered the standard of care in stage I seminoma?. J Clin Oncol 2005; 23 (suppl 16): 4520.
  24. Oliver RTD, Mason MD, van der Maase H et al. Radiotherapy versus single dose carboplatin in adjuvant treatment of stage I testicular seminoma: a randomised trial. Lancet 2005; 366: 293-300. PubMed
  25. Warde P, Gospodarowicz M. Adjuvant carbopaltin in stage I seminoma. Lancet 2005; 366: 267-8. PubMed
  26. Rosendal S, Kristensen E, Giraldi AGE. Seksuelle dysfunktioner hos mænd, der er behandlet for testikelkræft. Ugeskr Læger 2007; 169: 3941. PubMed
  27. Fung C, Fossa SD, Williams A, Travis LB. Long-term morbidity of testicular cancer treatment. Urol Clin North Am 2015; 42: 393-408. PMID: 26216826 PubMed
Annonse
Annonse